The present invention discloses synergistic herbal compositions comprising; (i) a Punica granatum fruit extract containing metal complex of punicalagins; (ii) optionally a Punica granatum seed extract; and (iii) at least one additional ingredient selected from the extract, fraction, phytochemical or mixtures thereof derived from Mangifera indica, Piper nigrum, Tagetes erecta and Syzygium cumini; process for their preparation, methods of treatment and use of such compositions for longevity and general health.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary and nutritional supplement for use as an integral component of nutritional supplements, dietary supplements, mineral supplements, herbal supplements, vitamin supplements in foods, beverages and medicated cosmetics; Plant extracts, other than essential oils, for use in the manufacture of dietary and nutritional supplements
3.
A HERBAL COMPOSITION FOR STRESS RELIEF AND PROMOTING SLEEP
Rosmarinus officinalisNelumbo nuciferaNelumbo nucifera; process for their preparation, methods of treatment and use of such compositions for stress relief and promoting sleep.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
Produits et services
Dietary, nutritional and pharmaceutical supplement for use as an integral component of nutritional supplements, therapeutic supplements, dietary supplements, mineral supplements, herbal supplements, vitamin supplements in foods, beverages and cosmetics; Plant extracts, other than essential oils, for use in the manufacture of dietary and nutritional supplements.
7.
ENRICHED ASPARAGUS RACEMOSUS ROOT COMPOSITION AND PROCESS FOR PREPARATION THEREOF
The present invention discloses synergistic enriched Asparagus racemosus root extract composition comprising; shatavarin I, dehydroshatavarin I, shatavarin IV, and shatavarin IX; process for the preparation; methods of treatment and use of the compositions for female health benefits.
The present invention discloses synergistic herbal compositions comprising combination of a first ingredient selected from Centella asiatica extract containing at least one component selected from magnesium salt or complex of asiatic acid and magnesium salt or complex of madecassic acid or mixtures thereof along with asiaticoside and madecassoside; and a second ingredient selected from extract, fraction, phytochemical or mixtures thereof derived from Theobroma cacao; process for their preparation, methods of treatment and use of such nootropic compositions for improving cognitive functions or mental abilities and gaming performance.
A gut microbiome may be modulated in a patient in need thereof, by administering a composition comprising 3-O-acetyl-11-keto-b-boswellic acid (AKBA) or an extract of Boswellia serrata comprising from 30% to 90% AKBA to the patient; wherein the composition is administered at a dose sufficient to change the ratio between a first organism in the gut microbiome and a second organism in the gut microbiome, compared to a subject not treated with the composition. Modulation of the gut microbiome with AKBA may be used to treat allergic pulmonary inflammation in the patient. Modulation of the gut microbiome with AKBA may be used to maintain diversity and/or increase a percentage of Bifidobacterium pseudolongum in the gut microbiome of the patient. The composition may further comprise a lyophilized probiotic bacteria. The composition may be administered in combination with a second composition comprising a lyophilized probiotic bacteria.
Punica granatumPunica granatumMangifera indica, Piper nigrum, Tagetes erectaSyzygium cuminiSyzygium cumini; process for their preparation, methods of treatment and use of such compositions for longevity and general health.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
DIETARY, NUTRITIONAL AND PHARMACEUTICAL SUPPLEMENT FOR USE AS AN INTEGRAL COMPONENT OF NUTRITIONAL SUPPLEMENT, THERAPEUTIC SUPPLEMENTS, DIETARY SUPPLEMENTS, MINERAL SUPPLEMENTS, HERBAL SUPPLEMENTS, VITAMIN SUPPLEMENTS IN FOODS, BEVERAGES AND COSMETICS; DIETARY SUPPLEMENTS; DIETARY FOOD SUPPLEMENTS; AND NUTRITIONAL SUPPLEMENTS
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
DIETARY, NUTRITIONAL AND PHARMACEUTICAL SUPPLEMENT FOR USE AS AN INTEGRAL COMPONENT OF NUTRITIONAL SUPPLEMENT, THERAPEUTIC SUPPLEMENTS, DIETARY SUPPLEMENTS, MINERAL SUPPLEMENTS, HERBAL SUPPLEMENTS, VITAMIN SUPPLEMENTS IN FOODS, BEVERAGES AND COSMETICS; DIETARY SUPPLEMENTS; DIETARY FOOD SUPPLEMENTS; AND NUTRITIONAL SUPPLEMENTS
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
DIETARY, NUTRITIONAL AND PHARMACEUTICAL SUPPLEMENT FOR USE AS AN INTEGRAL COMPONENT OF A NUTRITIONAL SUPPLEMENT, THERAPEUTIC SUPPLEMENTS, DIETARY SUPPLEMENTS, MINERAL SUPPLEMENTS, HERBAL SUPPLEMENTS, VITAMIN SUPPLEMENTS IN FOODS, BEVERAGES AND COSMETICS; DIETARY SUPPLEMENTS; DIETARY FOOD SUPPLEMENTS; AND DIETARY AND NUTRITIONAL SUPPLEMENTS
16.
SYNERGISTIC HERBAL COMPOSITIONS FOR PREVENTION, TREATMENT OR CONTROL OF PAIN AND/OR CARTILAGE REGENERATION
Disclosed herein is Synergistic herbal composition(s) comprising combination of a first ingredient selected from the extract(s), fraction(s), phytochemical(s) and mixtures thereof derived from Murraya koenigii and a second ingredient selected from the extract(s), fraction(s), phytochemical(s) and mixtures thereof derived from Coriandrum sativum or Curcuma amada for improving cartilage growth/repair/regeneration, improving joint mobility, reducing cartilage breakdown, reducing joint pain, reducing stiffness, reducing inflammation and/or treating/alleviating symptoms associated with osteoarthritis. The invention further provides method of improving cartilage growth/repair/regeneration, improving joint mobility, reducing cartilage breakdown, reducing joint pain, reducing stiffness, reducing inflammation and/or treating/alleviating symptoms associated with osteoarthritis in a human or animal.
GlycyrrhizaglabraTinospora cordifoliaZingiber officinale, Justicia adhatodaOcimum sanctum;Ocimum sanctum; process for their preparation, methods of treatment and use of such compositions for improving immunity and improving respiratory health that include allergic airway inflammation, cold and cough.
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
18.
SYNERGISTIC HERBAL COMPOSITIONS FOR IMMUNE BOOSTING AND RESPIRATORY HEALTH
Terminalia chebula Withania somnifera, Tinospora cordifolia and Andrographis paniculata Withania somnifera, Tinospora cordifolia and Andrographis paniculata; process for their preparation, methods of treatment and use of such compositions for improving immunity and respiratory health.
The present invention discloses water-soluble 3-O-acetyl-11-keto-β-boswellic acid compositions comprising 3-O-acetyl-11-keto-β-boswellic acid in combination with a metal ion selected from potassium or sodium in the form of respective metal salt or complex or chelate; process for their preparation; methods of prevention, control and/or treatment of at least one disorder selected from muscle soreness, delayed-onset of muscle soreness (DOMS), muscles tenderness, muscle pain, muscle fatigue, muscle sprain, temporary loss of muscle strength and swelling in muscles.
A61P 21/00 - Médicaments pour le traitement des troubles du système musculaire ou neuromusculaire
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
20.
SYNERGISTIC HERBAL COMPOSITIONS FOR IMPROVING GUT HEALTH
Abelmoschus esculentus, Withania somnifera and Amorphophallus paeoniifoliusAbelmoschus esculentus, Withania somnifera and Amorphophallus paeoniifolius; improving at least one gut health function selected from gut-brain axis, easing of constipation, bowel movement, improved GI motility, digestion and gut immunity; and reducing gut inflammation. The invention further relates to methods of treatment and the use of the compositions.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
DIETARY AND NUTRITIONALSUPPLEMENT FOR USE AS AN INTEGRAL COMPONENT OF NON-PHARMACEUTICAL NUTRITIONAL SUPPLEMENTS, THERAPEUTIC SUPPLEMENTS, DIETARY SUPPLEMENTS, MINERAL SUPPLEMENTS, HERBAL SUPPLEMENTS, VITAMIN SUPPLEMENTS IN FOODS, BEVERAGES AND COSMETICS; DIETARY SUPPLEMENTS; DIETARY FOOD SUPPLEMENTS; AND NUTRITIONAL SUPPLEMENTS; ALL OF THE AFOREMENTIONED NOT FOR USE WITH ANY PHARMACEUTICAL PRODUCTS
22.
SYNERGISTIC COMPOSITIONS FOR IMPROVING BRAIN HEALTH
The invention discloses synergistic herbal compositions comprising the first ingredient selected from the extract(s), fraction(s), phytochemical(s) and mixtures thereof derived from Terminalia chebula in combination with a second ingredient selected from the oil extract(s)/fraction(s) derived from Boswellia serrata gum resin for improving atleast one cognitive functions selected from memory, intelligence, learning, recall information/communication, focus, concentration, reasoning, problem solving, decision making and mental fatigue.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Dietary and nutritional supplements for general health and well-being, and active pharmaceutical ingredients for use in the manufacture of nutritional supplements for general health and well-being and therapeutic purposes, dietary supplements for general health and well-being, mineral supplements, herbal supplements for general health and well-being, vitamin supplements in foods, beverages and cosmetics; dietary supplements for general health and well-being; and nutritional supplements for general health and well-being
Syzygium cumini, Rubia cordifolia Mangifera indica Mangifera indica for treating/alleviating Sarcopenia, preventing muscle loss, improving muscle mass, improving exercise performance, stimulating muscle protein synthesis and improving recovery of muscle functionality after muscle atrophy. The invention further provides the method of treating Sarcopenia, loss of muscle mass, and/or method of improving at least one condition selected from exercise performance, stimulating muscle protein synthesis and recovery of muscle functionality after muscle atrophy in a human.
Withania somniferaWithania somnifera (Ashwagandha) extract composition comprising withanolide glycosides, withanolide aglycones and reduced levels of withaferin-A. The invention also provides to process for the preparation of these compositions and further provides to methods of improving testosterone levels, energy levels, sustained energy, vigor, stamina, and muscle mass and muscle strength using these compositions.
A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
A61K 31/58 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes contenant des hétérocycles, p. ex. danazol, stanozolol, pancuronium ou digitogénine
A61K 31/702 - Oligosaccharides, c.-à-d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Ashwagandha sold as an integral component of nutritional supplements, dietary supplements, mineral supplements, herbal supplements, and vitamin supplements for use in foods, beverages and cosmetics
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
DIETARY, NUTRITIONAL AND PHARMACEUTICAL SUPPLEMENT FOR USE AS AN INTEGRAL COMPONENT OF NUTRITIONAL SUPPLEMENT, THERAPEUTIC SUPPLEMENTS, DIETARY SUPPLEMENTS, MINERAL SUPPLEMENTS, HERBAL SUPPLEMENTS, VITAMIN SUPPLEMENTS IN FOODS, BEVERAGES AND COSMETICS; DIETARY SUPPLEMENTS; DIETARY FOOD SUPPLEMENTS; NUTRITIONAL SUPPLEMENTS.
29.
SYNERGISTIC HERBAL COMPOSITIONS FOR TESTOSTERONE BOOSTING
Synergistic herbal compositions comprising combination of a first ingredient selected from the extract(s), fraction(s), active compound(s) and phytochemicals or mixtures thereof derived from the plant parts of Punica granatum and a second ingredient selected from the extract(s), fraction(s), active compound(s) and phytochemicals or mixtures thereof derived from the plant parts of Theobroma cacao for improving testosterone levels. The invention further provides the method of obtaining at least one health benefit related to enhanced anabolic and androgenic activities in the body selected from improving testosterone levels, energy levels, sustained energy, vigor, stamina, healthy aging, cellular longevity, muscle mass, muscle strength sexual function (libido and erectile function) and psychological well-being (mood and focus); and reducing stress in humans and alleviating the symptoms associated with the low levels of testosterone in humans such as loss of libido, loss of erectile function, abdominal obesity, decreased muscle mass and strength, fatigue, mood swing, decreased bone density, decreased motivation, and decreased memory and concentration.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary, nutritional and pharmaceutical supplement for use as an integral component of nutritional supplement, therapeutic supplements, dietary supplements, mineral supplements, herbal supplements, vitamin supplements in foods, beverages and cosmetics; dietary supplements; dietary food supplements; and nutritional supplements
31.
SYNERGISTIC HERBAL COMPOSITIONS FOR THE TREATMENT OF OBESITY AND OVERWEIGHT
The invention discloses synergistic herbal composition comprising combination of first ingredient selected from extracts, fractions, phytochemicals and mixtures thereof derived from Theobroma cacao and a second ingredient selected from extracts, fractions, phytochemical and mixtures thereof derived from Citrus aurantifolia for obtaining at least one health benefit selected from preventing, controlling or treating obesity and/or overweight; improving lean body mass, improving the browning of White Adipose Tissue/improving formation of brown adipose tissue, increasing basal metabolic rate/resting energy expenditure, increasing thermogenesis, improving thyroid function, maintaining healthy body weight, increasing satiety/, supporting weight loss, improving fat loss and maintaining a slim body. The invention further discloses synergistic herbal compositions comprising Theobroma cacao and Citrus aurantifolia and optionally comprises at least one ingredient selected from pharmaceutically acceptable excipient/diluent/carrier; methods of treatment and use for the prevention and treatment of obesity/overweight or improving lean body mass or resting energy expenditure in a human or animal.
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
A61K 8/98 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés d'origine animale
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
32.
COMPOSITIONS FOR IMPROVING LEAN BODY MASS, BROWN ADIPOSE TISSUE AND FOR INHIBITING ADVANCED GLYCATION END PRODUCTS
Synergistic herbal compositions comprising combination of extracts, fractions or phytochemicals or mixtures thereof derived from Moringa oleifera, Murraya koenigii and Curcuma longa for increasing lean body mass and brown adipose tissue; for accelerating the conversion of the white adipose tissue (WAT) to brown adipose tissue (BAT), inhibiting excessive generation of advanced glycation end (AGE) products and disease conditions associated with increased levels of advanced glycation end (AGE) products. The invention further provides a method of increasing lean body mass and brown adipose tissue; accelerating the conversion of the white adipose tissue (WAT) to brown adipose tissue (BAT), inhibiting excessive generation of advanced glycation end (AGE) products and disease conditions associated with increased levels of advanced glycation end (AGE) products in mammals.
Synergistic herbal compositions for Testosterone boosting comprising at least two ingredients selected from the extracts, fractions or pure phytochemicals derived from Punica granatum, Cinnamomum zeylanicum, Nigella sativa, Brassica nigra and Mangifera indica for improving testosterone levels and alleviating symptoms associated with low levels of testosterone hormone in humans. The present invention also describes a synergistic composition comprising at least one testosterone booster ingredient selected from the extracts, fractions or pure phytochemical derived from Punica granatum, Cinnamomum zeylanicum, Nigella sativa, Brassica nigra and Mangifera indica and at least one aromatase inhibitor ingredient selected from the extracts, fractions or pure phytochemicals derived from Allium cepa, Tamarindus indica and Cinnamomum tamala for improving testosterone levels and alleviating symptoms associated with low levels of testosterone hormone in humans. The invention further provides methods of improving testosterone levels and alleviating symptoms associated with low levels of testosterone hormone in humans.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
DIETARY, NUTRITIONAL AND PHARMACEUTICAL SUPPLEMENT FOR USE AS AN INTEGRAL COMPONENT OF NUTRITIONAL SUPPLEMENTS, THERAPEUTIC SUPPLEMENTS, DIETARY SUPPLEMENTS, MINERAL SUPPLEMENTS, HERBAL SUPPLEMENTS, VITAMIN SUPPLEMENTS IN FOODS, BEVERAGES AND COSMETICS; DIETARY SUPPLEMENTS; DIETARY FOOD SUPPLEMENTS; AND DIETARY AND NUTRITIONAL SUPPLEMENTS
36.
DIETARY SUPPLEMENTS FOR INHIBITING PDE5 AND INCREASING CGMP LEVELS
The invention discloses synergistic compositions comprising extracts, fractions or pure compounds derived from at least two herbs selected from Punica granatum, Mangifera indica and Garcinia mangostana for inhibiting the expression/production/activity of Phosphodiesterase 5 (PDE5) enzyme or for increasing cGMP levels in a male subject. The invention further discloses a method of inhibiting the expression/production/activity of Phosphodiesterase 5 (PDE5) enzyme, increasing cGMP levels and sexual arousal, treating/ alleviating various aspects of male sexual dysfunction or impotence such as erectile dysfunction, loss of libido, or orgasm/ejaculation disorders in a male subject by using a suitable dose of synergistic composition comprising extracts, fractions or pure compounds derived from at least two herbs selected from Punica granatum, Mangifera indica and Garcinia mangostana.
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
37.
SYNERGISTIC DIETARY SUPPLEMENT COMPOSITIONS OF SPHAERANTHUS INDICUS AND TERMINALIA CHEBULA FOR LIVER HEALTH
Title of the invention: Synergistic Dietary Supplement Compositions of Sphaeranthus Indicus and Terminalia Chebula for Liver Health The invention discloses synergistic compositions comprising at least one component selected from extract(s) and fraction(s) or mixtures thereof derived from Sphaeranthus indicus in combination with at least one component selected from extract(s), fraction(s), active compound(s) or mixtures thereof derived from Terminalia chebula for improving the liver health. The invention further discloses method of improving the liver health in humans and animals by administering the compositions comprising at least one component selected from extract(s) and fraction(s) or mixtures thereof derived from Sphaeranthus indicus in combination with at least one component selected from extract(s), fraction(s), active compound(s) or mixtures thereof derived from Terminalia chebula.
A61K 36/28 - Asteraceae ou Compositae (famille de l'aster ou du tournesol), p. ex. camomille, chrysanthème matricaire, achillée ou echinacée
A61K 36/61 - Myrtaceae (famille du myrte), p. ex. cajeputier ou eucalyptus
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
38.
SYNERGISTIC DIETARY SUPPLEMENT COMPOSITIONS FOR IMPROVING BRAIN HEALTH
The present invention relates to synergistic compositions comprising extracts or fractions derived from Bacopa monnieri in combination with extracts or fractions derived from Terminalia chebula for improving brain health, memory/mental condition, enhancing brain/mental functions such as cognition, memory, learning, retention, communication and for treating neurodegenerative diseases/disorders such as Alzheimer's disease, Parkinson's disease etc. The invention further relates to method of improving brain health and brain functions selected from cognition, memory, memory retention, information recall, intelligence, motivation, attention, concentration, learning power and communication and to alleviate disease conditions related to cognition and memory deficits in a mammal by supplementing the mammal with an effective dose of the synergistic composition comprising at least one extract or fraction derived from Bacopa monnieri in combination with at least extract or fraction derived from Terminalia chebula.
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
The invention discloses odor masking formulations for stench natural compounds, selected from the extracts, fraction and pure phytochemicals that are produced in combination with a natural or synthetic hydrocolloid polymer gum(s). The invention further discloses novel process of producing the odor and taste masking formulations. The invention also discloses taste masking formulations of valerian extracts with no characteristic stench odor & or negligible stench odor in combination with natural hydrocolloid gum such as guar gum, acacia or other polymers. The invention further discloses method of reducing insomnia, anxiety, Attention Deficit Disorder (ADD), Chronic Fatigue Syndrome (CFS) using odor masking formulation of the current invention. Importantly, the said odor masked formulation of the present disclosure helps in improving sleep cycle and helps in efficient functioning of brain.
A61K 36/84 - Valerianaceae (famille de la valériane), p. ex. valériane
A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
A61K 47/34 - Composés macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. polyesters, acides polyaminés, polysiloxanes, polyphosphazines, copolymères de polyalkylène glycol ou de poloxamères
40.
TASTE MASKING FORMULATION FOR BITTER NATURAL COMPOUNDS
The invention discloses taste masking formulations for bitter natural compounds, selected from the extracts, fraction and pure phytochemicals produced in combination with a synthetic polymer or a natural polymer. The invention also relates to the novel process of producing the taste masking formulations. The invention also relates to taste masking formulations of Bacopa extracts with no bitter taste or negligible bitter taste in combination with synthetic polymers such as Eudragit or natural polymers such as Shellac.
A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
A61K 8/97 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base d’algues, de champignons, de lichens ou de plantesCosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de leurs dérivés
A61K 31/35 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à six chaînons avec un oxygène comme seul hétéro-atome d'un cycle
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Dietary and nutritional supplements for general health and well-being and pharmaceutical ingredients, namely combinations of cinnamomum tamala and garcinia mangostana, all for use as an integral component of nutritional supplements for general health and well-being or therapeutic purposes, dietary supplements for general health and well-being, mineral supplements, herbal supplements for general health and well-being, vitamin supplements.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary, nutritional and pharmaceutical supplement for use as an integral component of nutritional supplement, therapeutic supplements, dietary supplements, mineral supplements, herbal supplements, vitamin supplements in foods, beverages and cosmetics; dietary supplements; dietary food supplements; dietary and nutritional supplements.
The present invention relates to synergistic compositions for the treatment of one or more associated conditions of arthritis or rheumatoid arthritis osteoarthritis. More particularly, novel synergistic compositions which comprises a combination of therapeutically effective amounts of: a) an alcoholic/hydroalcoholic extract of Tamarindus indica seed comprising proanthocyanidins either alone or in combination with water extract of Tamarindus indica seed comprising polysaccharides, b) a Curcuma longa rhizome extract comprising curcuminoids, c) optionally containing pharmaceutically or nutraceutically or dietetically acceptable carriers/excipients. The invention also relates to a method of treating one or more associated conditions of arthritis or rheumatoid arthritis or osteoarthritis using synergistic composition.
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 31/353 - 3,4-Dihydrobenzopyranes, p. ex. chromane, catéchine
A61K 31/715 - Polysaccharides, c.-à-d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiquesLeurs dérivés, p. ex. éthers, esters
A61K 36/48 - Fabaceae ou Leguminosae (famille du pois ou des légumineuses)CaesalpiniaceaeMimosaceaePapilionaceae
A61K 36/9066 - Curcuma, p. ex. curcuma, zédoaire ou curcuma amada
A61K 45/00 - Préparations médicinales contenant des ingrédients actifs non prévus dans les groupes
45.
A COMPOSITION COMPRISING EXTRACT OF ALANGIUM SALVIFOLIUM HAVING ANTI-ADIPOGENIC OR ANTI-OBESIC ACTIVITY
The invention relates to herbal anti-adipogenic and pro-lipolytic composition(s) or phytochemical ingredients(s) comprising at least one component selected from the extract(s), fraction(s) and active compound(s) derived from Alangium salvifolium either alone or in combination with atleast one component selected from pharmaceutically or dietetically acceptable phytochemical actives, vehicle, diluent and carrier. The present novel ingredients or compositions can be used to control or treat overweight, obesity, metabolic syndrome or other metabolic disorders, regulate energy expenditure, prevention of atherosclerotic plaques in coronary artery and abdominal aorta, increase insulin sensitivity, improve glucose tolerance, lower triglyceride levels and balance glucose levels in mammals.
A61K 8/97 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base d’algues, de champignons, de lichens ou de plantesCosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de leurs dérivés
46.
SYNERGISTIC DIETARY SUPPLEMENT COMPOSITIONS FOR THE PREVENTION, TREATMENT OR CONTROL OF INFLAMMATORY DISORDERS
Disclosed herein is a novel synergistic dietary supplement composition(s)comprising extracts or fractions of Terminalia chebula, Curcuma longa and Boswellia serrata optionally with at least one ingredient selected from plant derived anti-inflammatory agents, pharmaceutically or nutraceutical or dietetically acceptable carriers/excipients, useful for preventing or treating inflammation or associated conditions thereof.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary, nutritional and pharmaceutical ingredient for use as an integral component of nutritional supplements, therapeutic supplements, dietary supplements, mineral supplements, herbal supplements, vitamin supplements in foods, beverages and cosmetics
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Dietary, nutritional and pharmaceutical supplement for use as an integral component of nutritional supplement, therapeutic supplements, dietary supplements, mineral supplements, herbal supplements, vitamin supplements in foods, beverages and cosmetics; dietary supplements; dietary food supplements and dietary and nutritional supplements.
49.
SYNERGISTIC DIETARY SUPPLEMENT FOR ENHANCING PHYSICAL PERFORMANCE
The present invention discloses novel synergistic dietary supplement compositions comprising at least two ingredients selected from the extracts and fractions derived from Sphaeranthus indicus, Cole us aromaticus, Cissus quadrangular is, Curcuma longa, Garcinia mangostana, Citrullus lanatus, Ocimum sanctum, Trachyspermum ammi and Cinnamomum tamala as natural energy enhancer for enhancing physical performance, muscle strength, muscle mass, mental alertness and energy levels in a mammal.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary and nutritional supplements and pharmaceutical ingredients, namely, Boswellia extracts, all for use as an integral component of nutritional supplements, therapeutic supplements, dietary supplements, mineral supplements, herbal supplements, vitamin supplements
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary and nutritional supplements and pharmaceutical ingredients, namely cinnamon plant extracts, all for use as an integral component of nutritional supplements, therapeutic supplements, dietary supplements, mineral supplements, herbal supplements, vitamin supplements
52.
COMPOSITIONS COMPRISING EXTRACTS OR FRACTIONS DERIVED FROM ANNONA SQUAMOSA FOR THE PREVENTION, TREATMENT OR CONTROL OF INFLAMMATORY AND METABOLIC DISORDERS
The invention discloses synergistic composition comprising at least one Annona squamosa derived component standardized to acetogenin compound(s) having α,β- unsaturated-y-methyl-y-lactone moiety in combination with at least one biologically active ingredient derived from plants, animals or microorganisms such as vitamins, amino acids, minerals, fibers, various plant and herbal extracts for the prevention, treatment, inhibition or controlling inflammation and/or metabolic disorders and other associated or related diseases. The invention further discloses the method of treating inflammation and/or metabolic disorders and other associated or related diseases.
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
53.
Extracts, fractions and compositions comprising acetogenins and their applications
Annona squamosa derived acetogenin(s), extract(s)/fraction(s) or their compositions for prevention, treatment, inhibition or controlling metabolic diseases/disorders.
A61P 3/10 - Médicaments pour le traitement des troubles du métabolisme de l'homéostase du glucose de l'hyperglycémie, p. ex. antidiabétiques
A61P 9/10 - Médicaments pour le traitement des troubles du système cardiovasculaire des maladies ischémiques ou athéroscléreuses, p. ex. médicaments antiangineux, vasodilatateurs coronariens, médicaments pour le traitement de l'infarctus du myocarde, de la rétinopathie, de l'insuffisance cérébro-vasculaire, de l'artériosclérose rénale
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary, Nutritional and Pharmaceutical ingredient for use as an integral component of nutritional supplements, therapeutic supplements, dietary supplements, mineral supplements, herbal supplements, vitamin supplements in foods, beverages and cosmetics
The invention discloses herbal ingredients derived from Sphaeranthus indicus standardized to at least one frullanolide/eudesmanoid sesquiterpene compound and their compositions as natural energy enhancer to provide an onset and steady maintenance of energy and mental alertness in a mammal. The invention further includes the use of ingredients and compositions for food ingredient formulations such as dietary supplement, food ingredient, beverage, snack or energy drink containing the above said herbal ingredient(s) for enhancing physical activity, physical fitness, mental alertness, enhancing energy levels, stamina levels, circulatory health, blood vessel health and for better mental health in warm blooded animal.
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
56.
7-HYDROXYFRULLANOLIDE AND ITS ANALOGS FOR PREVENTION, CONTROL AND TREATMENT OF METABOLIC DISORDERS
The invention discloses biologically active ingredient(s) selected from 7- hydroxyfrullanolide, its analogs, the extract(s) and fraction(s) standardized to 7- hydroxyfrullanolide or its analogs or both or mixtures thereof or their composition(s) for the prevention, control and treatment of one or more obesity, overweight, metabolic syndrome, diabetes and other metabolic disorders or for producing lean body mass in a warm blooded animal in need thereof.
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
57.
COMPOSITIONS COMPRISING NON-ACIDIC BOSWELLIA OIL FRACTION AS A BIO-ENHANCER FOR ENHANCING THE BIOAVAILABILITY OF BIOLOGICAL AGENTS
The invention relates to Boswellia derived fraction selected from non-acidic Boswellia low polar gum resin extract fraction (BLPRE), Boswellia volatile oil fraction (BVOIL) or Boswellia oil fraction (BOIL) comprising BLPRE and BVOIL in combination with biological agents for enhancing the bioavailability of said biological agents. The invention also provides composition(s) comprising at least one component selected from Boswellia oil (BOIL), Boswellia volatile oil (BVOIL) and Boswellia low polar gum resin extract (BLPRE) in combination with a biological agent for increasing the bioavailability of biological agent.
A01N 45/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés comportant au moins trois cycles carbocycliques condensés entre eux, un cycle au moins n'étant pas un cycle à six chaînons
C07C 69/74 - Esters d'acides carboxyliques dont un groupe carboxyle est lié à un atome de carbone d'un cycle autre qu'un cycle aromatique à six chaînons
A01N 37/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés organiques comportant un atome de carbone possédant trois liaisons à des hétéro-atomes, avec au plus deux liaisons à un halogène, p. ex. acides carboxyliques
A61K 31/20 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary, Nutritional and Pharmaceutical supplement for use as an integral component of nutritional supplement, therapeutic supplements, dietary supplements, mineral supplements, herbal supplements, vitamin supplements in foods, beverages and cosmetics; dietary supplements; dietary food supplements; and dietary and nutritional supplements
59.
BOSWELLIA OIL, ITS FRACTIONS AND COMPOSITIONS FOR ENHANCING BRAIN FUNCTION
The present invention discloses non-acidic extract/fraction selected from Boswellia low polar gum resin extract fraction (BLPRE), Boswellia volatile oil fraction (BVOIL) and Boswellia oil fraction (BOIL) derived from the gum resin of Boswellia species and their compositions for improving memory/mental condition, enhancing brain/mental functions such as cognition, memory, learning, communication and brain health, for treating impaired memory, and for preventing, control or treating memory and cognition related disorders/diseases.
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
60.
A NOVEL BOSWELLIA LOW POLAR GUM RESIN EXTRACT AND ITS SYNERGISTIC COMPOSITIONS
The present invention provides Boswellia low polar gum resin extract (BLPRE) comprising novel phytochemical composition of sesquiterpenes, diterpenes, triterpenes and other phytochemical(s) obtained from gum resin of Boswellia species. The invention also provides compositions comprising BLPRE in combination with one or more component(s) selected from biologically active ingredient(s), functional ingredient(s), excipient(s), diluents(s), carrier(s) and additive(s) or mixtures thereof. Further the invention also provides synergistic composition(s) comprising Boswellia low polar gum resin extract (BLPRE) and at least one component selected from but not limited to extract(s), fraction(s), phytochemical(s) or their salts or mixtures thereof derived from Boswellia species or Curcuma species.
A01N 61/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des substances de composition non connue ou indéterminée, p. ex. des substances caractérisées uniquement par leur mode d'action
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
A61K 31/00 - Préparations médicinales contenant des ingrédients actifs organiques
A61K 35/00 - Préparations médicinales contenant des substances ou leurs produits de réaction de constitution non déterminée
61.
AGENTS DERIVED FROM HOLOPTELEA INTEGRIFOLIA AND THEIR COMPOSITIONS FOR THE CONTROL OF METABOLIC SYNDROME AND ASSOCIATED DISEASES
The invention discloses phytochemical agents derived from Holoptelea integrifolia and novel composition(s) comprising at least one component selected from the extract(s), fraction(s) and active compound(s) for the protection and alleviation of Metabolic Syndrome,' insulin resistance, endothelial dysfunction, chronic kidney disease, atherosclerosis, diabetes and other disease 'conditions associated with metabolic syndrome. The invention also dislcoses the amelioration of certain biomarker molecules such as Peroxisome proliferator-activated receptor gamma (PPAR-y), Adipose Differentiation Related Protein (ADRP), CD36, Adipocyte Fatty-acid-Binding Protein (aP2IFABP-4/A~FABP), beta-3 Adrenergic Receptor (J33AR), Leptin, Perilipin and Adiponectin by using the phytochemical components, derived from Holoptelea integri folia.
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
62.
EXTRACTS, FRACTIONS AND COMPOSITIONS COMPRISING ACETOGENINS AND THEIR APPLICATIONS
The present invention discloses acetogenin(s), extract(s)/fraction(s) standardized to acetogenin(s) comprising terminal α,β-unsaturated-γ-methyl-γ-lactone moiety derived from Annona squamosa or their compositions for prevention, treatment, inhibition or controlling inflammation and immune related diseases or disorders mediated through cytokines/chemokines or other biomarkers. The invention further discloses said Annona squamosa derived acetogenin(s), extract(s)/fraction(s) or their compositions for prevention, treatment, inhibition or controlling metabolic diseases/disorders.
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
63.
AGENTS FROM FICUS HISPIDA FOR THE AMELIORATION OF METABOLIC SYNDROME AND RELATED DISEASES
The invention discloses herbal ingredient(s) derived from Ficus hispida comprising herb powder(s), extract(s), fraction(s), pure compound(s) or mixtures thereof and their compositions for alleviating metabolic disorders selected from metabolic syndrome, obesity, diabetes, atherosclerosis, endothelial dysfunction and other metabolic disorders or conditions; the for amelioration of different biological marker proteins and metabolic processes associated metabolic disorders.
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
64.
COMPOSITION FROM SPHAERANTHUS INDICUS AND GARCINIA MANGOSTANA FOR THE CONTROL OF METABOLIC SYNDROME
The invention relates pharmaceutical/dietary supplement/food ingredient(s) selected from the extract(s), fraction(s), active compound(s) and phytochemical(s) or mixtures thereof derived from Sphaeranthus indicus and their compositions, preferably in combination with at least one component selected from the extract(s), fraction(s), active compound(s) and phytochemical(s) or mixtures thereof derived from Garcinia mangostana. The ingredients and the composition(s) can be used for the control, prevention and treatment of obesity, metabolic syndrome, diabetes and other metabolic disorders, and also to regulate energy expenditure, prevention of atherosclerotic plaques in coronary artery and abdominal aorta, increase insulin sensitivity, improve glucose tolerance, lower triglyceride levels and balance glucose levels in mammals.
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
The present invention discloses synergistic nutraceutical or pharmaceutical or dietary supplement anti-inflammatory compositions comprising therapeutically effective combination of an extract selectively enriched in 3-O-acetyl-1 1-keto-β- boswellic acid (AKBA) derived from Boswellia serrata and Boswellia serrata non- acidic resin extract (BNRE). The composition(s) can be used to prevent, control and treat inflammation and several inflammatory related diseases including asthma, osteoarthritis, rheumatoid arthritis, endothelial dysfunction and the like. The invention further discloses the amelioration of pro-inflammatory biomarker proteins or molecules, whose expression/production is altered during inflammatory diseases.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary, nutritional and pharmaceutical ingredient sold as an integral component of nutritional supplements, therapeutic supplements, dietary supplements, mineral supplements, herbal supplements, and vitamin supplements
68.
'SYNERGISTIC HERBAL COMPOSITIONS FOR TESTOSTERONE BOOSTING
Synergistic herbal compositions for Testosterone boosting comprising at least two ingredients selected from the extracts, fractions or pure phytochemicals derived from Punica granatum, Cinnamomum zeylanicum, Nigella sativa, Brassica nigra and Mangifera indica for improving testosterone levels and alleviating symptoms associated with low levels of testosterone hormone in humans. The present invention also describes a synergistic composition comprising at least one testosterone booster ingredient selected from the extracts, fractions or pure phytochemical derived from Punica granatum, Cinnamomum zeylanicum, Nigella sativa, Brassica nigra and Mangifera indica and at least one aromatase inhibitor ingredient selected from the extracts, fractions or pure phytochemicals derived from Allium cepa, Tamarindus indica and Cinnamomum tamala for improving testosterone levels and alleviating symptoms associated with low levels of testosterone hormone in humans. The invention further provides methods of improving testosterone levels and alleviating symptoms associated with low levels of testosterone hormone in humans.
